Skip to main content

Table 3 Clinical symptoms before and after amikacin treatment

From: Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

Clinical symptom

Before treatment (n = 13)

After treatment (n = 13)

P value*

Cough

12 (92.3 %)

9 (69.2 %)

0.027

Sputum

11 (84.6 %)

7 (53.8 %)

0.182

Dyspnea

5 (38.5 %)

2 (15.4 %)

0.114

Hemoptysis

3 (23.1 %)

0 (0.0 %)

0.004

Fever

2 (15.4 %)

1 (7.7 %)

0.009

Fatigue

2 (15.4 %)

1 (7.7 %)

0.009

Night sweat

0 (0.0 %)

0 (0.0 %)

-

  1. Data are presented as n (%) *:McNemar’s test